License-Out | What's New | iPS Academia Japan, Inc.

2018/10/29

License-Out

License Agreement Has Been Entered with Asahi Kasei Corp.

We executed a worldwide license agreement with Asahi Kasei Corp. (Tokyo, Japan) for the use of iPS cell-derived cartilage for regenerative t...

results 41 - 50 of 87

2018/09/28

License-Out

We executed a non-exclusive license agreement with SCAD for providing their products related to iPS cell-derived cardiomyocytes for research...

2018/09/06

License-Out

We executed a non-exclusive license agreement with Novoheart Limited (Hong Kong) for providing their products and services related to iPS ce...

2018/06/08

License-Out

We have been executed a non-exclusive license agreement with IRBM (Italy) for provision of services using iPS cell-derived cells based on th...

2018/06/01

License-Out

We have entered into a non-exclusive license agreement with NEXEL Co., Ltd. (South Korea), under which NEXEL Co., Ltd. is allowed to sell iP...

2018/05/22

License-Out

We have executed a non-exclusive license agreement with Katholieke Universiteit Leuven (Belgium) for provision of services using iPS cell-de...

2018/05/16

License-Out

We have executed a non-exclusive license agreement with iXCells Biotechnologies USA, Inc. which provides products and services related to iP...

2018/03/15

License-Out

We executed a non-exclusive license agreement with Platelet Biogenesis, Inc. (Cambridge, U.S.A.) for the use of iPS cell-derived platelet pr...

2018/02/19

License-Out

We executed a non-exclusive license agreement with Stemnovate Ltd. which provides services related to iPS cells for research use, on the pat...

2018/01/29

License-Out

We have executed a non-exclusive license agreement with Elpis Biomed Limited, under which Elpis generates iPS cell-derived, differentiated h...

results 1 - 10 of 87　